Nine Malaysian hospitals to work with WHO for drug trials on COVID-19
By Akshay Kedari  Date: 2020-04-06

Nine Malaysian hospitals to work with WHO for drug trials on COVID-19

With the growing COVID-19 crisis, various initiatives are being taken worldwide where numerous organizations of various scale and are contributing as much as they can towards the efforts. The WHO, the biggest global authority responsible for international public health, is planning a solidarity trial to test various drugs that could help fight the coronavirus.

In a recent press release, the WHO, in collaboration with the Health Ministry of Malaysia, announced that the country has been selected to be a participant in the “Solidarity Trial”. Nine hospitals across Malaysia have been selected and would very soon initiate drug testing for coronavirus.   

Health Director-General, Datuk Dr. Noor Hisham Abdullah stated that the Health Ministry has expedited the process to conduct drug testing for the treatment of coronavirus patients. The trials would be conducted under the safety standards that are set by the National Pharmaceutical Regulatory Agency.

Dr. Noor further added that the participation of Malaysia in this global trial might help discover life-saving medicines to combat COVID-19 by evaluating their effectiveness and safety. Clinical Research Malaysia and Institute for Clinical Research of the Health Ministry of Malaysia would also help with the implementation of drug trials across the nation.

Queen Elizabeth Hospital, Sarawak General Hospital, Tengku Ampuan Afzan Hospital, Melaka Hospital, Kuala Lumpur Hospital, Sungai Buloh Hospital, Penang Hospital, Sultanah Bahiyah Hospital, and Tuanku Fauziah Hospital are the nine hospitals that have been selected from Malaysia to conduct trails of several drugs.       

Dr. Chow Ting Soo will lead the research and drug trials in Malaysia, and would also have access to a team of 16 Infectious Disease pharmacists and physicians working in their respective hospitals. Dr. Soo is an Infectious Disease Consultant in Penang Hospital.

The drug trials would primarily test the effectiveness of four different treatment protocols utilizing various combinations of five drugs which include Hydroxychloroquine, Chloroquine, Interferon beta, Lopinavir/Ritonavir, and Remdesivir.

Source credit: https://www.thestar.com.my/news/nation/2020/04/06/covid-19-nine-m039sian-hospitals-to-start-who-global-drug-trial

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Innovaccer unveils AI-enabled patient relationship management solution
Innovaccer unveils AI-enabled patient relationship management solution
By Akshay Kedari

Innovaccer, Inc., a healthcare company, has recently launched an AI (artificial intelligence) enabled patient relationship management solution. The new solution will streamline communication between the care teams and patients. In addition, the solu...

Geely Tech to rollout a smart battery swapping network across Jinan
Geely Tech to rollout a smart battery swapping network across Jinan
By Akshay Kedari

Geely Technology Group, a Chinese automobile manufacturer, and the Municipal Government of Jinan, China, have reportedly signed an all-round strategic cooperation deal to jointly develop a network of smart battery swapping service stations across Jin...

CStone Pharmaceuticals, Pfizer finalize a $200 million share sale deal
CStone Pharmaceuticals, Pfizer finalize a $200 million share sale deal
By Akshay Kedari

Chinese biotechnology company, CStone Pharmaceuticals has recently announced that it has completed the Share Subscription Agreement with Pfizer Inc. for its newly issued shares worth US$200 million. The move furthers the biotech’s multifaceted ...

Researchers bag $6Mn grant to study the link between Parkinson’s & aging
Researchers bag $6Mn grant to study the link between Parkinson’s & aging
By Akshay Kedari

A three-year grant worth $6 million, funded by the Michael J. Fox Foundation, was recently awarded to a collaborative research team from Michigan’s Van Andel Institute (VAI) and the University of Minnesota Medical School. The grant was given th...

EY announces availability of OpsChain Network Procurement solution
EY announces availability of OpsChain Network Procurement solution
By Akshay Kedari

Ernst & Young (EY), a global professional services network, has recently announced the availability of a first-of-its-kind OpsChain Network Procurement solution. The solution has been built on the company’s OpsChain platform. It will enabl...